文献速递甲状腺疾病

良性甲状腺结节热消融后的生活质量:系统综述与荟萃分析

Quality of Life Following Thermal Ablation of Benign Thyroid Nodules: A Systematic Review and Meta-Analysis.
PubMed 文献 · Thyroid · 2025-11-10

该系统综述与荟萃分析评估了良性甲状腺结节热消融后使用验证工具测量的生活质量结局。共纳入13项研究,其中4项进入荟萃分析。结果显示生活质量通常在术后3至6个月改善,但不同甲状腺特异性生活质量维度的改善一致性存在差异。

要点

  • 热消融后整体生活质量改善较一致,但压迫和美容维度改善一致性较低
  • ThyPRO多数维度平均差异有统计学改善,但跨时间点一致性不一
  • 部分维度平均差异超过最小重要变化,提示临床意义

核心结论

  • 良性甲状腺结节热消融后生活质量通常在3至6个月改善,但甲状腺特异性生活质量各维度改善存在变异性。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、Embase、Scopus、EBSCO和ProQuest至2025年12月8日。
  • 纳入13项研究(随机对照试验3项、队列研究3项、前后对照研究7项),基线样本量14至120。
  • 消融技术包括射频(7项)、激光(3项)和微波(3项)。

主要发现

  • 整体生活质量改善见于9项研究中的8项,压迫相关生活质量改善见于5项中的4项,美容相关生活质量改善见于4项中的2项。
  • ThyPRO多数维度平均差异有统计学改善,但跨时间点改善一致性不一。
  • 平均差异超过最小重要变化的维度包括:甲状腺肿(全部4个时间点)、焦虑(仅≤1个月)、认知/抑郁/情绪易感性(仅≤1个月和12个月)、美容/甲亢/眼部(仅12个月)。

关键数值与推荐

  • 生活质量改善一般在3至6个月显现,长期耐久性可变。
  • ThyPRO各维度平均差异超过最小重要变化的情况因维度和时间点而异。

临床怎么用

  • 热消融可作为改善良性甲状腺结节患者生活质量的选项,但应告知不同维度改善程度和时间存在差异。
  • 随访中应关注甲状腺特异性生活质量,特别是整体、压迫和美容维度。

局限性

  • 研究间数值报告不一致且随访间隔异质,限制可比性。
  • 其他生活质量工具因使用稀疏且时间点各异未能合并分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Benign thyroid nodules (BTNs) may cause significant compressive symptoms and cosmetic concerns. Thermal ablation has emerged as an alternative to resection, but its impact on quality of life (QOL) has not been thoroughly evaluated. Our objective was to evaluate the existing literature for QOL outcomes, as measured by validated instruments, after BTN thermal ablation. Methods: MEDLINE, Embase, Scopus, EBSCO, and ProQuest Dissertations & Theses Global were searched through December 8, 2025. Studies in English reporting QOL using validated instruments for thermal ablation of BTNs were included. Three reviewers completed article screening, data extraction, and risk of bias assessments (RoBANS 2 and Cochrane Collaboration's tool). Pooled mean differences (MDs) in QOL were calculated for Thyroid-Related Patient-Reported Outcome (ThyPRO) scales using a random-effects model and the inverse-variance approach; pooling was not possible for other instruments due to sparse utilization across varied time points across studies. Results: Of the 72 articles screened, the review included 13, and the meta-analysis included 4. The included studies were randomized controlled trials (3), cohort studies (3), or pre/post studies (7). The baseline sample sizes ranged from 14 to 120. Ablation techniques included radiofrequency (7 studies), laser (3), and microwave (3). QOL instruments included two thyroid-specific (ThyPRO: 7 studies, Patient-Reported Outcome Measure for Parathyroid and Thyroid disease, or PROMPT: 1), one dysphagia-specific (Swallowing Quality of Life tool, or SWAL-QOL: 1), and three generic (2 Short Form scales, SF-12: 2 and SF-36: 4, EuroQol-5 dimension-3 level scale (EQ-5D-3L): 1) instruments. QOL improvements generally became apparent between three and six months; long-term durability was variable. Improvements in overall QOL (8 of 9 studies) were more consistent than improvements in compressive QOL (4 of 5 studies) or cosmetic QOL (2 of 4 studies). ThyPRO domain MDs statistically improved for most scales, although the consistency of improvement across time points varied. MDs exceeded minimal important changes (MICs) for goiter (all four time points); anxiety (≤1 month only); cognition, depressivity, and emotional susceptibility (≤1 month and 12 months only); and cosmetic, hyperthyroid, and eye domains (12 months only). Conclusions: QOL generally improves between three and six months after BTN ablation, although variability is seen across thyroid-specific QOL domains. Study comparability was limited by inconsistent numeric reporting and heterogenous follow-up intervals. Future research should utilize thyroid-specific instruments, extend follow-up beyond one year, include inferential within-subject repeated measures analyses, and contextualize the clinical meaningfulness of QOL changes using MICs.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Kowalski R, Park A, Abdulgader L, et al. Quality of Life Following Thermal Ablation of Benign Thyroid Nodules: A Systematic Review and Meta-Analysis. Thyroid. 2025. PMID: 41213637. doi:10.1177/10507256251393520

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。